Liu, Feng-Di <br/><br/>
Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.  [electronic resource] 

 -  Scientific reports  05 2018 
 - 7408 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-25820-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood-Brain Barrier--metabolism<br/>Brain Ischemia--complications<br/>Diabetes Mellitus, Experimental--complications<br/>Intracranial Hemorrhages--complications<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Occludin--metabolism<br/>Permeability<br/>Rats<br/>Rats, Sprague-Dawley<br/>Risk<br/>Rivaroxaban--pharmacology<br/>Stroke--complications<br/>Thrombectomy